Posterior Pituitary: Oxytocin - The Love & Labor Hormone

- Source: Synthesized in the paraventricular nuclei of the hypothalamus; stored and released from the posterior pituitary.
- Physiologic Functions:
- Stimulates uterine smooth muscle contraction during labor.
- Triggers myoepithelial cell contraction in the breast for milk letdown (ejection).
- Associated with social bonding and maternal behaviors.
- Clinical Use (as Pitocin):
- Induction and augmentation of labor.
- Control of postpartum hemorrhage by contracting the uterus.
- Adverse Effects:
- Uterine hyperstimulation, potentially causing fetal distress.
- Hypotension and reflex tachycardia.
⭐ High-Yield: At high doses, oxytocin has an antidiuretic effect due to its structural similarity to ADH. This can lead to water retention, hyponatremia, and seizures.
Posterior Pituitary: ADH Agonists - The Water & Pressure Pressers
- Mechanism: Synthetic analogs of ADH that act on vasopressin (V) receptors. V1 receptors mediate vasoconstriction; V2 receptors mediate antidiuresis via aquaporin-2 insertion in renal collecting ducts.
| Drug | Mechanism | Primary Uses | Key Side Effects |
|---|---|---|---|
| Desmopressin | Selective V2 agonist | Central Diabetes Insipidus (DI), nocturnal enuresis, von Willebrand disease, Hemophilia A | Hyponatremia, headache, flushing |
| Vasopressin | Non-selective V1 & V2 agonist | Septic shock (vasopressor), esophageal variceal hemorrhage | Ischemia (coronary, mesenteric), hyponatremia, hypertension |
- **Conivaptan** (IV): V1a/V2 antagonist
- **Tolvaptan** (oral): Selective V2 antagonist
⭐ High-Yield: Desmopressin-induced hyponatremia can cause seizures. Monitor sodium levels closely, especially in children (enuresis) and the elderly. Fluid restriction is often necessary.
📌 Mnemonic: "Vaps" & "tans" are for Vasopressin. Conivaptan/Tolvaptan block ADH, while Vasopressin/Desmopressin mimic it.
Posterior Pituitary: ADH Antagonists - The Vaptan Clan
- Mechanism: Block ADH (vasopressin) action at the V2 receptor in the collecting duct, promoting free water excretion (aquaresis) without affecting sodium excretion.
- Indications: Euvolemic and hypervolemic hyponatremia (e.g., SIADH, heart failure, cirrhosis).
| Drug | Route | Receptor | Clinical Pearl |
|---|---|---|---|
| Conivaptan | IV | V1a/V2 | For inpatient/emergent use. |
| Tolvaptan | Oral | V2 selective | For outpatient use; limited to <30 days due to hepatotoxicity. |
- Hypernatremia, dehydration
- Central Pontine Myelinolysis (CPM) if hyponatremia is corrected too rapidly.
- Tolvaptan: Hepatotoxicity (Black Box Warning).
⭐ High-Yield: Avoid rapid correction of hyponatremia. The goal is a slow increase in serum sodium, typically <8-10 mEq/L in the first 24 hours to prevent osmotic demyelination syndrome.
High‑Yield Points - ⚡ Biggest Takeaways
- Oxytocin is crucial for inducing labor and controlling postpartum hemorrhage.
- ADH (vasopressin) acts on V2 receptors in collecting ducts, promoting water reabsorption to regulate plasma osmolality.
- Desmopressin (DDAVP) is the primary treatment for central diabetes insipidus and von Willebrand disease.
- ADH antagonists (e.g., tolvaptan) are key for treating SIADH by blocking ADH effects.
- Central DI is an insufficient ADH problem, whereas nephrogenic DI is an ADH receptor problem.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app